CloudMD (DOC.C): Perhaps this might be a good time to talk about investing in telemedicine

As happens whenever a global crisis hits, there are plenty of investors currently watching the global Coronavirus outbreak and looking to panic sell. There are also a few looking to capitalize on the opportunities found in potential doom. Like folks who buy gun stocks whenever a military conflict breaks out, or those who buy gold as a safe haven when the world's leaders engage in a game of 'Armageddon chicken.' a pandemic brings about macroeconomic changes that can be utilised to make money.

Invictus MD Strategies (GENE.V) kicked off Venture Exchange after screwing up everything for three years straight

Invictus MD Strategies (GENE.V) announced tonight that, in accordance with its efforts to work through creditor protection proceedings, it has been kicked off the Venture Exchange. On the upside, if Invictus' history of going back on news releases is anything to go by, we'll receive another release inside ten days that the bankruptcy proceedings have been cancelled and they'll continue on as usual. Because that's how it's always been for Invictus, which has the worst track record in Canada's cannabis space for announcing things, only to un-announce them very shortly after.

2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed

Respect where it's due, I haven't been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year's Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn't the biggest show around, but they know how to turn out the playahs, and the only way you keep big money showing up is to be a little bit picky with what you offer them. Don't waste anyone's time and they'll know it's cool to return.

Wayland Group (WAYL.C) selling once hyped foreign assets for pennies on the dollar

As part of an ongoing process to deal with its bankruptcy, Wayland Group (WAYL.C) is dispensing with several foreign assets that were once touted as being amazing international opportunities, and it's doing so at prices you can afford. The courts have granted approval for WAYL to get rid of its Colombian subsidiary, Colmed Pharmaceuticals, which was purchased in an all paper deal for 11 million shares a little over a year ago. Who's buying it? It turns out, one of the companies that originally sold it to them, RG5 Investments.

If the cannabis industry is desperate for capital, time to bet on the guys with capital

With a little over and hour left in the year 2019, past 10PM on December 31, I saw a news release from James E. Wagner Cultivation (JWCA.V) about a small $2 million loan they'd taken out. The timing of the announcement of their loan was surely not coincidental. Actually, thinking about it, 'payday loan' might be the more appropriate term to have used. JVCA took out a debenture financing of $2 million at an interest rate of 25% annually. That's just the first tranche of the deal; there's another $8 million out there if they want it. My credit card, abused as it has been, costs me less interest to maintain than JWCA's loan.

1933 Industries (TGIF.C) blows up, jumps 35% preceding California harvest announcement

You've gotta love it when a plan comes together: 1933 Industries (TGIF.C), which has been banging the same 'we're grownups, we're doing it right, hang tight' drum for several years now, dropped news this February 14 that will make any Valentine's heart swell with joy. "Following the completion of a combined 20,000-square-foot expanded cultivation, extraction, manufacturing and distribution facility in the Los Angeles area, the company began harvesting its first cannabis crop this week to be utilized for both its proprietary brand Alternative Medicine Association (AMA), as well as for its licensing partner luxury brand Blonde cannabis, with products earmarked for dispensaries for the first time outside of Nevada."

Fire in the hole: Supreme Cannabis (FIRE.T) drops rough financials as expected, transition afoot

Ontario-based Supreme Cannabis (FIRE.T) released its Q2 2020 financials today and there were few surprises contained in its pages, bar perhaps the size of the quarterly loss. At a $17.3 million net loss after taxes (and a $10.4 million loss in adjusted EBITDA terms), FIRE shares fell in value below the $0.40 mark it's been hovering around for some time, a 5% drop in real terms. Previous quarters had seen smaller losses, even come close to break even. But even the rosiest-eyed fanboy would have expected these numbers to be rough, considering the CEO change and staff layoffs announced earlier in the year.  We predicted as much a week ago.

Hold your FIRE: Supreme Cannabis (FIRE.T) lays off staff in bid for balance sheet superiority

Large Canadian cannabis licensed producer Supreme Cannabis (FIRE.T) told the markets they're laying off around 30% of their staff today, days before their next quarterly financials are released and with the dust still settling after their recent CEO change. To the casual observer, this might appear to be a sign of desperation, that the sky is falling in Kincardine, Ontario, and the owner of the esteemed 7 Acres brand was making some sort of last ditch effort to stave off Armageddon. It ain't that.

Vivus (VVUS.Q) jumps 47% after FDA approval of improved Pancreaze pancreatic medication

If you’ve had your eye off the biotech sector recently because it doesn’t directly involve gold or cannabis, you’re missing out on one of the better casinos out there. For the high risk, high reward investor, nothing is quite like the thrill of correctly picking when a long, drawn out, US Food and Drug Administration process of approving a new drug finally gets over the line.